Şimdi başlat
ABBVIE INCABBVIE INCABBVIE INC

ABBVIE INC

İşlem yok
Süper-grafiklerde görün
Genel Bakış Finansal Haberler Fikirler Tartışmalar Teknikler Tahmin Mevsimlik
Tahvil

ABBVCL tahvilleri

Aşağıda ABBVIE INC şirket tahvillerinin listesi bulunmaktadır. Yatırımcılar genellikle piyasa dalgalanması zamanlarında artan istikrarları için bir şirketin tahvillerini tercih ederler. Fiyatları, getirileri ve diğer istatistikleri inceleyin ve güvenilir bir yatırım bulun.
Sembol
Vade sonu getirisi %
Hacim
Fiyat %
Kupon %
Vade Tarihi
Ödenmemiş tutar
Nominal değer
Asgari brm tutarı
İhraççı
ABBV4241910AbbVie Inc. 3.6% 14-MAY-2025
20,59%10,06 M99,91%3,60%2025-05-143,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
7,83%26 K76,04%4,75%2045-03-1553,51 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
7,77%16 K77,52%4,85%2044-06-1565,23 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
7,67%50 K77,25%4,63%2042-10-0167,49 M USD1.000,00 USD2.000,00 USDActavis, Inc.
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
6,76%1 M86,91%4,55%2035-03-15107,65 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
4ABIABBVIE 20/49
6,34%079,93%4,25%2049-11-215,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAW9ABBVIE 16/46
6,24%083,71%4,45%2046-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAM1ABBVIE 2042
6,17%085,08%4,40%2042-11-062,6 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABBABBVIE 15/45
6,13%087,17%4,70%2045-05-142,7 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
6,13%378 K87,67%4,75%2045-03-15827,09 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABFABBVIE 18/48
6,11%088,08%4,88%2048-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
6,09%5 M89,03%4,85%2044-06-151,01 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
6,05%16,83 M84,54%4,05%2039-11-214 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YDX4ABBVIE 24/64
6,02%093,98%5,50%2064-03-151,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5,98%144 K88,45%4,63%2042-10-01389,22 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YDW6ABBVIE 24/54
5,92%094,42%5,40%2054-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YEB1ABBVIE 25/55
5,90%096,78%5,60%2055-03-15750 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YDV8ABBVIE 24/44
5,88%095,30%5,35%2044-03-15750 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5,74%26 K90,47%3,20%2029-11-2162,52 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAV1ABBVIE 16/36
5,53%091,59%4,30%2036-05-141 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4241923AbbVie Inc. 4.5% 14-MAY-2035
5,41%19,1 M94,11%4,50%2035-05-142,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
5,41%2,94 M94,50%4,55%2035-03-151,68 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YEA3ABBVIE 25/35
5,27%099,55%5,20%2035-03-151 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YDU0ABBVIE 24/34
5,18%099,21%5,05%2034-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4,82%4,42 M93,98%3,20%2029-11-215,44 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YDT3ABBVIE 24/31
4,75%0100,89%4,95%2031-03-152 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YDZ9ABBVIE 25/30
4,69%0100,72%4,88%2030-03-151 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YDS5ABBVIE 24/29
4,62%0100,58%4,80%2029-03-152,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
4,48%1,13 M97,81%2,95%2026-11-213,99 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YDY2ABBVIE 25/28
4,45%0100,50%4,65%2028-03-151,25 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAY5ABBVIE 16/26
4,44%098,81%3,20%2026-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YBF5ABBVIE 18/28
4,42%099,49%4,25%2028-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YDR7ABBVIE 24/27
4,39%0100,70%4,80%2027-03-152,25 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
AA19H80ALLERGAN FUNDING SCS 2017-01.06.29 GUARANTEED SERIES 12Y3,99%093,48%2,13%2029-06-0136,46 M EUR1.000,00 EUR100.000,00 EURAllergan Funding SCS
XS190919331ALLERGAN FNDG 18/28
3,89%096,08%2,63%2028-11-1572,11 M EUR1.000,00 EUR100.000,00 EURAllergan Funding SCS
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
3,86%096,53%2,95%2026-11-219,24 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABGABBVIE 19/31
3,37%088,68%1,25%2031-11-18650 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS212591491ABBVIE 20/29
2,90%097,17%2,13%2029-06-01506,09 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
2,90%0121,31%4,25%2049-11-214,95 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
2,88%0126,76%4,75%2045-03-155 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
2,83%0128,71%4,85%2044-06-15100 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
XS212591483ABBVIE 20/28
2,75%099,59%2,63%2028-11-15427,79 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS152090781ABBVIE 16/28
2,73%098,05%2,13%2028-11-17750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
4ABEABBVIE 19/27
2,64%095,53%0,75%2027-11-18750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2,35%0123,74%4,55%2035-03-151 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
———4,40%2042-11-061,1 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.